2023 Q2 Form 10-K Financial Statement

#000117184323004114 Filed on June 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023
Revenue $388.3M $1.405B
YoY Change 10.37% 15.93%
Cost Of Revenue $223.6M $805.9M
YoY Change 13.82% 21.43%
Gross Profit $164.7M $599.6M
YoY Change 6.0% 9.27%
Gross Profit Margin 42.42% 42.66%
Selling, General & Admin $148.0M $529.6M
YoY Change 27.22% 239.18%
% of Gross Profit 89.83% 88.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.605M $5.602M
YoY Change 32.64% 38.9%
% of Gross Profit 0.97% 0.93%
Operating Expenses $149.6M $535.2M
YoY Change 27.28% 242.76%
Operating Profit $15.15M $64.47M
YoY Change -60.01% -83.58%
Interest Expense -$12.85M -$38.31M
YoY Change 269.31% -450.87%
% of Operating Profit -84.84% -59.43%
Other Income/Expense, Net
YoY Change
Pretax Income $2.253M $25.79M
YoY Change -93.44% -78.58%
Income Tax $165.0K $5.362M
% Of Pretax Income 7.32% 20.79%
Net Earnings $2.078M $20.39M
YoY Change -92.21% -78.15%
Net Earnings / Revenue 0.54% 1.45%
Basic Earnings Per Share $3.20
Diluted Earnings Per Share $0.32 $3.11
COMMON SHARES
Basic Shares Outstanding 6.371M 6.371M
Diluted Shares Outstanding 6.567M

Balance Sheet

Concept 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.796M $9.796M
YoY Change 41.64% 41.64%
Cash & Equivalents $9.796M $9.796M
Short-Term Investments
Other Short-Term Assets $21.43M $21.43M
YoY Change 136.94% 136.94%
Inventory $109.3M $109.3M
Prepaid Expenses
Receivables $6.115M $6.115M
Other Receivables $9.259M $9.259M
Total Short-Term Assets $155.9M $155.9M
YoY Change 14.24% 14.24%
LONG-TERM ASSETS
Property, Plant & Equipment $61.68M $120.8M
YoY Change 19.92% 9.58%
Goodwill $11.70M
YoY Change 36.05%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $58.24M $58.24M
YoY Change 63.26% 63.26%
Total Long-Term Assets $1.265B $1.265B
YoY Change 25.34% 25.34%
TOTAL ASSETS
Total Short-Term Assets $155.9M $155.9M
Total Long-Term Assets $1.265B $1.265B
Total Assets $1.420B $1.420B
YoY Change 24.02% 24.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.20M $27.20M
YoY Change 35.61% 35.61%
Accrued Expenses $87.73M $87.73M
YoY Change 1.43% 1.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $114.9M $114.9M
YoY Change 7.05% 7.05%
LONG-TERM LIABILITIES
Long-Term Debt $638.6M $638.6M
YoY Change 44.92% 44.92%
Other Long-Term Liabilities $128.6M $128.6M
YoY Change 28.5% 28.5%
Total Long-Term Liabilities $767.2M $767.2M
YoY Change 41.88% 41.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $114.9M $114.9M
Total Long-Term Liabilities $767.2M $767.2M
Total Liabilities $921.5M $921.6M
YoY Change 36.41% 36.4%
SHAREHOLDERS EQUITY
Retained Earnings $685.8M
YoY Change 4.19%
Common Stock $110.1M
YoY Change 6.6%
Preferred Stock
YoY Change
Treasury Stock (at cost) $297.4M
YoY Change 1.78%
Treasury Stock Shares
Shareholders Equity $498.4M $498.8M
YoY Change
Total Liabilities & Shareholders Equity $1.420B $1.420B
YoY Change 24.02% 24.02%

Cashflow Statement

Concept 2023 Q2 2023
OPERATING ACTIVITIES
Net Income $2.078M $20.39M
YoY Change -92.21% -78.15%
Depreciation, Depletion And Amortization $1.605M $5.602M
YoY Change 32.64% 38.9%
Cash From Operating Activities -$14.63M -$138.0M
YoY Change 26.02% 20.73%
INVESTING ACTIVITIES
Capital Expenditures $159.0K $22.23M
YoY Change -102.26% 6.28%
Acquisitions
YoY Change
Other Investing Activities -$133.0K -$3.092M
YoY Change 2560.0% 133.71%
Cash From Investing Activities -$292.0K -$25.33M
YoY Change -95.86% 13.86%
FINANCING ACTIVITIES
Cash Dividend Paid $40.00K
YoY Change 0.0%
Common Stock Issuance & Retirement, Net $64.00K -$3.694M
YoY Change -110.74%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 17.49M 188.7M
YoY Change -70.17% 7.11%
NET CHANGE
Cash From Operating Activities -14.63M -138.0M
Cash From Investing Activities -292.0K -25.33M
Cash From Financing Activities 17.49M 188.7M
Net Change In Cash 2.563M 25.45M
YoY Change -93.59% -35.89%
FREE CASH FLOW
Cash From Operating Activities -$14.63M -$138.0M
Capital Expenditures $159.0K $22.23M
Free Cash Flow -$14.79M -$160.2M
YoY Change 223.51% 18.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000799850
CY2023 dei Entity Registrant Name
EntityRegistrantName
AMERICAS CAR-MART INC
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13701468
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13642185
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6373404
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6371977
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7328064
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7270208
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
106590
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
304204
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
57856
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
65.95
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
150.83
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
41.86
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
41.86
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-04-30
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
0-14939
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
63-0851141
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1805 North 2nd Street, Suite 401
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Rogers
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
AR
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
72756
CY2023 dei City Area Code
CityAreaCode
479
CY2023 dei Local Phone Number
LocalPhoneNumber
464-9944
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023 dei Trading Symbol
TradingSymbol
CRMT
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
397198739 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6371404
CY2023 dei Auditor Firm
AuditorFirmId
248
CY2023 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2023 dei Auditor Location
AuditorLocation
Tulsa, Oklahoma
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9796000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6916000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
58238000 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
35671000 usd
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
6115000 usd
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
4926000 usd
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
1073764000 usd
CY2022Q2 us-gaap Notes Receivable Net
NotesReceivableNet
863674000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
109290000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
115302000 usd
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9259000 usd
CY2022Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
274000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
21429000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
15070000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
59142000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58828000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
11716000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
8623000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61682000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45412000 usd
CY2023Q2 us-gaap Assets
Assets
1420431000 usd
CY2022Q2 us-gaap Assets
Assets
1154696000 usd
CY2023Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
27196000 usd
CY2022Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
20055000 usd
CY2023Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
33606000 usd
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
32630000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
39315000 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
30449000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
62300000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
61481000 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
471367000 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
395986000 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
167231000 usd
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
44670000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
921484000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
677762000 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
400000 usd
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
400000 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
137000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
136000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
109929000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
103113000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
685802000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
665410000 usd
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
297421000 usd
CY2022Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
292225000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
498447000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
476434000 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
100000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
100000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
498547000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
476534000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1420431000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1154696000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1209279000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1043698000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
799129000 usd
CY2023 us-gaap Interest And Fee Income Loans Consumer Installment Automobiles Marine And Other Vehicles
InterestAndFeeIncomeLoansConsumerInstallmentAutomobilesMarineAndOtherVehicles
196219000 usd
CY2022 us-gaap Interest And Fee Income Loans Consumer Installment Automobiles Marine And Other Vehicles
InterestAndFeeIncomeLoansConsumerInstallmentAutomobilesMarineAndOtherVehicles
151853000 usd
CY2021 us-gaap Interest And Fee Income Loans Consumer Installment Automobiles Marine And Other Vehicles
InterestAndFeeIncomeLoansConsumerInstallmentAutomobilesMarineAndOtherVehicles
110545000 usd
CY2023 us-gaap Revenues
Revenues
1405498000 usd
CY2022 us-gaap Revenues
Revenues
1195551000 usd
CY2021 us-gaap Revenues
Revenues
909674000 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
805873000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
663631000 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
479153000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
176696000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
156130000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
130855000 usd
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
352860000 usd
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
238054000 usd
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
153835000 usd
CY2023 us-gaap Interest Expense
InterestExpense
38312000 usd
CY2022 us-gaap Interest Expense
InterestExpense
10919000 usd
CY2021 us-gaap Interest Expense
InterestExpense
6820000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5602000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4033000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3719000 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-361000 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-149000 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
40000 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
1379704000 usd
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
1072916000 usd
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
774342000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
25794000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
122635000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
135332000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5362000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27621000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30512000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
20432000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
95014000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
104820000 usd
CY2023 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-40000 usd
CY2022 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-40000 usd
CY2021 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-40000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20392000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
94974000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
104780000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.20
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
14.59
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
15.81
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.11
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
13.92
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
15.05
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6371229
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6509673
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6628749
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6566896
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6823481
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6961575
CY2023 us-gaap Profit Loss
ProfitLoss
20432000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
95014000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
104820000 usd
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
352860000 usd
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
238054000 usd
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
153835000 usd
CY2023 crmt Payment Protection Plan Losses
PaymentProtectionPlanLosses
25107000 usd
CY2022 crmt Payment Protection Plan Losses
PaymentProtectionPlanLosses
21871000 usd
CY2021 crmt Payment Protection Plan Losses
PaymentProtectionPlanLosses
18954000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5602000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4033000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3719000 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5461000 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
775000 usd
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
391000 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-361000 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-149000 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
40000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
5314000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
5496000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
5962000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8866000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8750000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7239000 usd
CY2023 crmt Originations Of Financing Receivables
OriginationsOfFinancingReceivables
1161132000 usd
CY2022 crmt Originations Of Financing Receivables
OriginationsOfFinancingReceivables
1009858000 usd
CY2021 crmt Originations Of Financing Receivables
OriginationsOfFinancingReceivables
762717000 usd
CY2023 crmt Proceeds From Collection Of Finance Receivables Operating Activities
ProceedsFromCollectionOfFinanceReceivablesOperatingActivities
434458000 usd
CY2022 crmt Proceeds From Collection Of Finance Receivables Operating Activities
ProceedsFromCollectionOfFinanceReceivablesOperatingActivities
417796000 usd
CY2021 crmt Proceeds From Collection Of Finance Receivables Operating Activities
ProceedsFromCollectionOfFinanceReceivablesOperatingActivities
370254000 usd
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1188000 usd
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1559000 usd
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
269000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-133047000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-51057000 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5019000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6245000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7994000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1679000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8621000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5167000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14766000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-8984000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-424000 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3691000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-135728000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-119178000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53812000 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5549000 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1574000 usd
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22106000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15796000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8952000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
84000 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
20000 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
694000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27571000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17350000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8258000 usd
CY2023 crmt Proceeds Payments From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsPaymentsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1216000 usd
CY2022 crmt Proceeds Payments From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsPaymentsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
-1488000 usd
CY2021 crmt Proceeds Payments From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsPaymentsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4034000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
286000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
293000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
258000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5196000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
34698000 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10616000 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
40000 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
40000 usd
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
40000 usd
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2263000 usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6108000 usd
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
282000 usd
CY2023 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
CY2022 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-1802000 usd
CY2021 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
1802000 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
400176000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
399994000 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
327276000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
524000 usd
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
524531000 usd
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
331113000 usd
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
73337000 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
402688000 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
511042000 usd
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
62566000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
188746000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
176222000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5403000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25447000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
39694000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-56667000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42587000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2893000 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
59560000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68034000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42587000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2893000 usd
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
307539000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
258000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4034000 usd
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10616000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5962000 usd
CY2021 us-gaap Dividends
Dividends
40000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
104820000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
411957000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
293000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-1488000 usd
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
34698000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5496000 usd
CY2022 us-gaap Dividends
Dividends
40000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
95014000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
476534000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
286000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1217000 usd
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5196000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5314000 usd
CY2023 us-gaap Dividends
Dividends
40000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
20432000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
498547000 usd
CY2023 us-gaap Late Fee Income Generated By Servicing Financial Assets Amount
LateFeeIncomeGeneratedByServicingFinancialAssetsAmount
4400000 usd
CY2022 us-gaap Late Fee Income Generated By Servicing Financial Assets Amount
LateFeeIncomeGeneratedByServicingFinancialAssetsAmount
3100000 usd
CY2021 us-gaap Late Fee Income Generated By Servicing Financial Assets Amount
LateFeeIncomeGeneratedByServicingFinancialAssetsAmount
2500000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
26800000 usd
CY2023 crmt Number Of Operating Subsidiaries
NumberOfOperatingSubsidiaries
2 pure
CY2023 crmt Number Of Dealerships Operated
NumberOfDealershipsOperated
156 pure
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. Significant estimates include, but are <em style="font: inherit;">not</em> limited to, the Company’s allowance for credit losses.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Concentration of Risk</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company provides financing in connection with the sale of substantially all of its vehicles. These sales are made primarily to customers residing in Alabama, Arkansas, Georgia, Illinois, Kentucky, Mississippi, Missouri, Oklahoma, Tennessee, and Texas, with approximately 28.0% of revenues resulting from sales to Arkansas customers.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of <em style="font: inherit;"> April 30, 2023, </em>and periodically throughout the year, the Company maintained cash in financial institutions in excess of the amounts insured by the federal government. The cash is held in several highly rated banking institutions. The Company regularly monitors its counterparty credit risk and mitigates exposure by limiting the amount it invests in <em style="font: inherit;">one</em> institution.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
58238000 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
35671000 usd
CY2023 crmt Average Finance Receivable Interest Rate
AverageFinanceReceivableInterestRate
0.167 pure
CY2022Q4 crmt Financing Receivable Interest Rate
FinancingReceivableInterestRate
0.18 pure
crmt Financing Receivable Interest Rate
FinancingReceivableInterestRate
0.165 pure
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
6100000 usd
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
4900000 usd
CY2023 crmt Finance Receivables Customer Payments Due Either Weekly Or Bi Weekly Percentage
FinanceReceivablesCustomerPaymentsDueEitherWeeklyOrBiWeeklyPercentage
0.79 pure
CY2023Q2 crmt Financing Receivable Greater Than Or Equal To30 Days Past Due Percent Of Portfolio
FinancingReceivableGreaterThanOrEqualTo30DaysPastDuePercentOfPortfolio
0.036 pure
CY2022Q2 crmt Financing Receivable Greater Than Or Equal To30 Days Past Due Percent Of Portfolio
FinancingReceivableGreaterThanOrEqualTo30DaysPastDuePercentOfPortfolio
0.030 pure
CY2023 crmt Average Age Of Account At Charge Off Date
AverageAgeOfAccountAtChargeOffDate
P12Y3M18D
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
16500000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q2 us-gaap Goodwill
Goodwill
11700000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
8600000 usd
CY2023 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
3100000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
5800000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
5000000.0 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
2900000 usd
CY2020Q2 us-gaap Notes Receivable Net
NotesReceivableNet
472401000 usd
CY2023Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1209279000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1043698000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
799129000 usd
CY2023Q2 crmt Financing Receivable Recorded Investment Greater Than90 Days Past Due
FinancingReceivableRecordedInvestmentGreaterThan90DaysPastDue
3900000 usd
CY2022Q2 crmt Financing Receivable Recorded Investment Greater Than90 Days Past Due
FinancingReceivableRecordedInvestmentGreaterThan90DaysPastDue
3000000.0 usd
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50 pure
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06 pure
CY2023 crmt Defined Contribution Plan Employer Contribution Amount
DefinedContributionPlanEmployerContributionAmount
1200000 usd
CY2022 crmt Defined Contribution Plan Employer Contribution Amount
DefinedContributionPlanEmployerContributionAmount
1200000 usd
CY2021 crmt Defined Contribution Plan Employer Contribution Amount
DefinedContributionPlanEmployerContributionAmount
908000 usd
CY2023 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
558000 usd
CY2022 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
1400000 usd
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
57856
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
304204
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
106590
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5200000 usd
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
34700000 usd
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10600000 usd
CY2023 crmt Treasury Stock Shares To Establish Reserve Account To Secure Service Contracts
TreasuryStockSharesToEstablishReserveAccountToSecureServiceContracts
10000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y10M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0440 pure
CY2023 crmt Financing Receivable Interest Rate
FinancingReceivableInterestRate
0.180 pure
CY2023Q2 crmt Finance Receivables Number Of Loan Classes
FinanceReceivablesNumberOfLoanClasses
1 pure
CY2023Q2 crmt Finance Receivables Number Of Risk Pools
FinanceReceivablesNumberOfRiskPools
1 pure
CY2023Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
1752149000 usd
CY2022Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
1378803000 usd
CY2023Q2 us-gaap Deferred Discounts Finance Charges And Interest Included In Receivables
DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables
378777000 usd
CY2022Q2 us-gaap Deferred Discounts Finance Charges And Interest Included In Receivables
DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables
277306000 usd
CY2023Q2 crmt Finance Receivable Principal Balance
FinanceReceivablePrincipalBalance
1373372000 usd
CY2022Q2 crmt Finance Receivable Principal Balance
FinanceReceivablePrincipalBalance
1101497000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
299608000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
237823000 usd
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
1073764000 usd
CY2022Q2 us-gaap Notes Receivable Net
NotesReceivableNet
863674000 usd
CY2022Q2 us-gaap Notes Receivable Net
NotesReceivableNet
863674000 usd
CY2021Q2 us-gaap Notes Receivable Net
NotesReceivableNet
632270000 usd
CY2023 crmt Finance Receivable Originations
FinanceReceivableOriginations
1161132000 usd
CY2022 crmt Finance Receivable Originations
FinanceReceivableOriginations
1009858000 usd
CY2021 crmt Finance Receivable Originations
FinanceReceivableOriginations
762717000 usd
CY2023 crmt Finance Receivable Collections
FinanceReceivableCollections
434458000 usd
CY2022 crmt Finance Receivable Collections
FinanceReceivableCollections
417796000 usd
CY2021 crmt Finance Receivable Collections
FinanceReceivableCollections
370254000 usd
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
352860000 usd
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
238054000 usd
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
153835000 usd
CY2023 crmt Losses On Claims For Payment Protection Plan
LossesOnClaimsForPaymentProtectionPlan
25107000 usd
CY2022 crmt Losses On Claims For Payment Protection Plan
LossesOnClaimsForPaymentProtectionPlan
21871000 usd
CY2021 crmt Losses On Claims For Payment Protection Plan
LossesOnClaimsForPaymentProtectionPlan
18954000 usd
CY2023 crmt Inventory Acquired In Repossession And Payment Protection Plan Claims
InventoryAcquiredInRepossessionAndPaymentProtectionPlanClaims
138617000 usd
CY2022 crmt Inventory Acquired In Repossession And Payment Protection Plan Claims
InventoryAcquiredInRepossessionAndPaymentProtectionPlanClaims
100734000 usd
CY2021 crmt Inventory Acquired In Repossession And Payment Protection Plan Claims
InventoryAcquiredInRepossessionAndPaymentProtectionPlanClaims
59805000 usd
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
1073764000 usd
CY2022Q2 us-gaap Notes Receivable Net
NotesReceivableNet
863674000 usd
CY2021Q2 us-gaap Notes Receivable Net
NotesReceivableNet
632270000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
237823000 usd
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
177267000 usd
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
148781000 usd
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
352860000 usd
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
238054000 usd
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
153835000 usd
CY2023 crmt Financing Receivable Allowance For Credit Losses Writeoffs Net Of Recoveries
FinancingReceivableAllowanceForCreditLossesWriteoffsNetOfRecoveries
291075000 usd
CY2022 crmt Financing Receivable Allowance For Credit Losses Writeoffs Net Of Recoveries
FinancingReceivableAllowanceForCreditLossesWriteoffsNetOfRecoveries
177498000 usd
CY2021 crmt Financing Receivable Allowance For Credit Losses Writeoffs Net Of Recoveries
FinancingReceivableAllowanceForCreditLossesWriteoffsNetOfRecoveries
125349000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
299608000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
237823000 usd
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
177267000 usd
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
2500000 usd
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
2400000 usd
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1900000 usd
CY2020Q2 crmt Finance Receivables Allowance Percent Of Principle Balance
FinanceReceivablesAllowancePercentOfPrincipleBalance
0.2543 pure
CY2021Q2 crmt Finance Receivables Allowance Percent Of Principle Balance
FinanceReceivablesAllowancePercentOfPrincipleBalance
0.2355 pure
CY2021Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-14200000 usd
CY2022Q2 crmt Finance Receivables Allowance Percent Of Principle Balance
FinanceReceivablesAllowancePercentOfPrincipleBalance
0.2357 pure
CY2023Q2 crmt Finance Receivables Allowance Percent Of Principle Balance
FinanceReceivablesAllowancePercentOfPrincipleBalance
0.2391 pure
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3679000 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
4060000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
558000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1356000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1401000 usd
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-271000 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-455000 usd
CY2023Q2 crmt Finance Receivable Principal Balance
FinanceReceivablePrincipalBalance
1373372000 usd
CY2023Q2 crmt Financing Receivable Percent Of Portfolio
FinancingReceivablePercentOfPortfolio
1.0000 pure
CY2022Q2 crmt Finance Receivable Principal Balance
FinanceReceivablePrincipalBalance
1101497000 usd
CY2022Q2 crmt Financing Receivable Percent Of Portfolio
FinancingReceivablePercentOfPortfolio
1.0000 pure
CY2023 crmt Average Collected Amount Per Customer Per Month
AverageCollectedAmountPerCustomerPerMonth
534000 usd
CY2022 crmt Average Collected Amount Per Customer Per Month
AverageCollectedAmountPerCustomerPerMonth
513000 usd
CY2023Q2 crmt Principal Collected As A Percent Of Average Financing Receivables
PrincipalCollectedAsAPercentOfAverageFinancingReceivables
0.347 pure
CY2022Q2 crmt Principal Collected As A Percent Of Average Financing Receivables
PrincipalCollectedAsAPercentOfAverageFinancingReceivables
0.435 pure
CY2023 crmt Average Downpayment Percentage
AverageDownpaymentPercentage
0.054 pure
CY2022 crmt Average Downpayment Percentage
AverageDownpaymentPercentage
0.064 pure
CY2023 crmt Average Originating Contract Term
AverageOriginatingContractTerm
P42M27D
CY2022 crmt Average Originating Contract Term
AverageOriginatingContractTerm
P40M6D
CY2023 crmt Portfolio Weighted Average Contract Term Including Modifications
PortfolioWeightedAverageContractTermIncludingModifications
P46Y3M18D
CY2022 crmt Portfolio Weighted Average Contract Term Including Modifications
PortfolioWeightedAverageContractTermIncludingModifications
P42Y10M24D
CY2023Q2 crmt Finance Receivables Total Increase Decrease In Dollars Collected Per Active Customer Percentage
FinanceReceivablesTotalIncreaseDecreaseInDollarsCollectedPerActiveCustomerPercentage
0.041 pure
CY2022 crmt Increase Decrease In Average Selling Price
IncreaseDecreaseInAverageSellingPrice
1708 usd
CY2022 crmt Increase Decrease In Average Selling Price Percentage
IncreaseDecreaseInAverageSellingPricePercentage
0.104 pure
CY2023Q2 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
897296000 usd
CY2023Q2 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
373029000 usd
CY2023Q2 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
94154000 usd
CY2023Q2 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
7417000 usd
CY2023Q2 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
962000 usd
CY2023Q2 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
514000 usd
CY2023Q2 crmt Finance Receivable Principal Balance
FinanceReceivablePrincipalBalance
1373372000 usd
CY2023Q2 crmt Financing Receivable Percent Of Portfolio
FinancingReceivablePercentOfPortfolio
1.000 pure
CY2022Q2 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
786471000 usd
CY2022Q2 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
268454000 usd
CY2022Q2 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
43951000 usd
CY2022Q2 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
2467000 usd
CY2022Q2 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
129000 usd
CY2022Q2 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
25000 usd
CY2022Q2 crmt Finance Receivable Principal Balance
FinanceReceivablePrincipalBalance
1101497000 usd
CY2022Q2 crmt Financing Receivable Percent Of Portfolio
FinancingReceivablePercentOfPortfolio
1.000 pure
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-567000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45078000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41002000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61682000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45412000 usd
CY2023Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
11197000 usd
CY2022Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
12865000 usd
CY2023Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
8543000 usd
CY2022Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
7388000 usd
CY2023Q2 crmt Reserve For Claims
ReserveForClaims
5694000 usd
CY2022Q2 crmt Reserve For Claims
ReserveForClaims
4761000 usd
CY2023Q2 crmt Fair Value Of Contingent Consideration Liability
FairValueOfContingentConsiderationLiability
1943000 usd
CY2022Q2 crmt Fair Value Of Contingent Consideration Liability
FairValueOfContingentConsiderationLiability
3544000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
6229000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
4072000 usd
CY2023Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
33606000 usd
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
32630000 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
167231000 usd
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
44670000 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
471367000 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
395986000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
638598000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
440656000 usd
CY2022Q4 crmt Fair Value Inputs Discount Rate Intercompany Transactions
FairValueInputsDiscountRateIntercompanyTransactions
0.385 pure
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-3504000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
18871000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
23273000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8866000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8750000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7239000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5362000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27621000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30512000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5417000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
25753000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
28420000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
774000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5362000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27621000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30512000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
47486000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
37682000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3262000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1368000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
281000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
194000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
51029000 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
39244000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
3051000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
2524000 usd
CY2023Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
204000 usd
CY2022Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
316000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4634000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3561000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
164000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
168000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
3661000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
2226000 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
11714000 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8795000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
39315000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
30449000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6371229
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6509673
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6628749
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
195667
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
313808
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
332826
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6566896
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6823481
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6961575
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5300000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4100000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5500000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4200000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6000000.0 usd
CY2021 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4600000 usd
CY2023Q2 crmt Minimum Exercise Price As A Percentage Of Fair Market Value At Date Of Grant
MinimumExercisePriceAsAPercentageOfFairMarketValueAtDateOfGrant
1 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2033-02-20
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
260000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9100000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8400000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0360 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0086 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0036 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.55 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.51 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.50 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
140000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
CY2023 crmt Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
5100000 usd
CY2022 crmt Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
2100000 usd
CY2021 crmt Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
2000000.0 usd
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
667750
CY2020 crmt Proceeds From Stock Options Exercised Outstanding
ProceedsFromStockOptionsExercisedOutstanding
45777000 usd
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
68.55
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
CY2021 crmt Proceeds From Stock Options Exercised Granted
ProceedsFromStockOptionsExercisedGranted
1979000 usd
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
65.95
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
131350
CY2021 crmt Proceeds From Stock Options Exercised2
ProceedsFromStockOptionsExercised2
6730000 usd
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
51.24
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
-0
CY2021 crmt Proceeds On Shares Cancelled
ProceedsOnSharesCancelled
-0 usd
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
566400
CY2021 crmt Proceeds From Stock Options Exercised Outstanding
ProceedsFromStockOptionsExercisedOutstanding
41026000 usd
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
72.43
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
CY2022 crmt Proceeds From Stock Options Exercised Granted
ProceedsFromStockOptionsExercisedGranted
4525000 usd
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
150.83
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
94000
CY2022 crmt Proceeds From Stock Options Exercised2
ProceedsFromStockOptionsExercised2
6276000 usd
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
66.76
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1000
CY2022 crmt Proceeds On Shares Cancelled
ProceedsOnSharesCancelled
42000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
501400
CY2022 crmt Proceeds From Stock Options Exercised Outstanding
ProceedsFromStockOptionsExercisedOutstanding
39232000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
78.25
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
140000
CY2023 crmt Proceeds From Stock Options Exercised Granted
ProceedsFromStockOptionsExercisedGranted
9687000 usd
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
69.19
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
28000
CY2023 crmt Proceeds From Stock Options Exercised2
ProceedsFromStockOptionsExercised2
1439000 usd
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
51.38
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
-0
CY2023 crmt Proceeds On Shares Cancelled
ProceedsOnSharesCancelled
-0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
613400
CY2023 crmt Proceeds From Stock Options Exercised Outstanding
ProceedsFromStockOptionsExercisedOutstanding
47480000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
77.41
CY2023 crmt Stock Options Exercised
StockOptionsExercised
28000
CY2022 crmt Stock Options Exercised
StockOptionsExercised
94000
CY2021 crmt Stock Options Exercised
StockOptionsExercised
131350
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1216000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
591000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5120000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1412000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7124000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7894000 usd
CY2023 crmt Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Through Net Settlements
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedThroughNetSettlements
5000
CY2023 crmt Share Based Compensation Arrangement By Share Based Payment Award Options Reduction In Shares Issued To Satisfy The Exercise Price And Applicable Withholding Taxes
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsReductionInSharesIssuedToSatisfyTheExercisePriceAndApplicableWithholdingTaxes
2584
CY2023 crmt Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Through Net Settlements Net Of Shares To Satisfy The Exercise Price And Applicable Withholding Taxes
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedThroughNetSettlementsNetOfSharesToSatisfyTheExercisePriceAndApplicableWithholdingTaxes
2416
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
303400
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
4400000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y7M6D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
82.89
CY2023Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2850000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7782000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7770000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7232000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6720000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6137000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
46546000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
82187000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19887000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
62300000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
82200000 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
9000000.0 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
8000000.0 usd
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
8000000.0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
36605000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
10421000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
7029000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5480000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19238000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26964000 usd
CY2023 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
127035000 usd
CY2022 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
84096000 usd
CY2021 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
50868000 usd
CY2023 crmt Net Settlement Option Exercises
NetSettlementOptionExercises
223000 usd
CY2022 crmt Net Settlement Option Exercises
NetSettlementOptionExercises
5685000 usd
CY2021 crmt Net Settlement Option Exercises
NetSettlementOptionExercises
1616000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2307000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3176000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2510000 usd
CY2023 crmt Rightofuse Asset Obtained In Exchange For Operating Lease Liability Through Acquisitions
RightofuseAssetObtainedInExchangeForOperatingLeaseLiabilityThroughAcquisitions
0 usd
CY2022 crmt Rightofuse Asset Obtained In Exchange For Operating Lease Liability Through Acquisitions
RightofuseAssetObtainedInExchangeForOperatingLeaseLiabilityThroughAcquisitions
0 usd
CY2021 crmt Rightofuse Asset Obtained In Exchange For Operating Lease Liability Through Acquisitions
RightofuseAssetObtainedInExchangeForOperatingLeaseLiabilityThroughAcquisitions
0 usd
CY2022Q2 us-gaap Notes Receivable Net
NotesReceivableNet
863674000 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
30449000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
665410000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001171843-23-004114-index-headers.html Edgar Link pending
0001171843-23-004114-index.html Edgar Link pending
0001171843-23-004114.txt Edgar Link pending
0001171843-23-004114-xbrl.zip Edgar Link pending
comp_border.jpg Edgar Link pending
crmt-20230430.xsd Edgar Link pending
crmt20230430_10k.htm Edgar Link pending
ex_536174.htm Edgar Link pending
ex_536175.htm Edgar Link pending
ex_536176.htm Edgar Link pending
ex_536177.htm Edgar Link pending
ex_536178.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
crmt-20230430_def.xml Edgar Link unprocessable
crmt-20230430_lab.xml Edgar Link unprocessable
crmt-20230430_pre.xml Edgar Link unprocessable
crmt20230430_10k_htm.xml Edgar Link completed
crmt-20230430_cal.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending